agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Agilon Health Shares Surge 117.76% to $60.65 on Upgraded 2026 Guidance: Agilon Health shares surged 117.76%, closing at $60.65 after trading between $41.91 and $63.87, following an increased full-year 2026 guidance. This represented the company’s largest one-day gain post-earnings, underscoring investor confidence in its healthcare technology initiatives.
| Metric | Value |
|---|---|
| Price | $80.01 |
| Market Cap | $1.45B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.11% |
| 52-Week High | $152.00 |
| 52-Week Low | $7.48 |
| Volume | 177 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.82B |
| Net Income | $-354.54M |
| Gross Margin | 0.00% |
15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.